I think you've hit it exactly. There's no reason to think that resolving IP concerns will speed up production and deployment in India. Problems there have more to do with the state of their logistical and healthcare infrastructure than the (very impressive) vaccine production capabilities of the Serum Institute of India.

It's also maybe a little relevant that the Modi government didn't order nearly enough vaccines early enough.

I’m not sure I understand why we aren’t? In my area it seems there are now plenty of vaccine doses to go around now. Anyone can walk in to one of the various vaccine clinics set up by the county and get it. No appointment, no ID, no insurance needed. When I went they were practically begging me to spread the word to friends and family.

At a time when the US has vaccinated under 50% of its population - https://www.washingtonpost.com/graphics/2020/health/covid-va... - do you think it's possible that perhaps your area might not be a fully representative sample?

The US is finally allowing vaccine exports. The ban lifted May 1. It will take time to ramp up though.

Unfortunately the defense production act is still active. Curevac for example reports production issues:

https://www.reuters.com/business/healthcare-pharmaceuticals/...